ProShare Advisors’s OptiNose OPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-876
Closed -$19.2K 1955
2024
Q1
$19.2K Buy
876
+72
+9% +$1.6K ﹤0.01% 1973
2023
Q4
$15.6K Sell
804
-317
-28% -$5.79K ﹤0.01% 1931
2023
Q3
$20.7K Buy
1,121
+6
+0.5% +$108 ﹤0.01% 1786
2023
Q2
$20.6K Buy
+1,115
New +$26.4K ﹤0.01% 1833
2022
Q1
Sell
-772
Closed -$19K 2272
2021
Q4
$19K Buy
+772
New +$25.8K ﹤0.01% 2332
2020
Q4
Sell
-844
Closed -$49K 2099
2020
Q3
$49K Buy
844
+75
+10% +$5.55K ﹤0.01% 1594
2020
Q2
$86K Buy
+769
New +$54.7K ﹤0.01% 1584
2020
Q1
Sell
-886
Closed -$123K 1462
2019
Q4
$123K Sell
886
-51
-5% -$6.61K ﹤0.01% 1671
2019
Q3
$98K Sell
937
-1
-0.1% -$100 ﹤0.01% 1550
2019
Q2
$100K Sell
938
-135
-13% -$17.8K ﹤0.01% 1531
2019
Q1
$166K Buy
1,073
+6
+0.6% +$696 ﹤0.01% 1506
2018
Q4
$99K Buy
+1,067
New +$152K ﹤0.01% 1473

Other funds holding OPTN

ProShare Advisors's OPTN Position: Q2 2024 in Review

ProShare Advisors sold out of OptiNose (OPTN) in Q2 2024, closing a stake of 876 shares — an estimated $19.2K sold.

ProShare Advisors first reported a position in OPTN in Q4 2018 and held it in 12 quarters. The position peaked at $166K in Q1 2019. 84 funds tracked by Wall St. Rank hold OPTN as of Q2 2024.

  • ProShare Advisors reported no remaining OptiNose position as of Q2 2024 after selling out during the quarter.
  • ProShare Advisors sold 876 OptiNose shares in Q2 2024, an estimated $19.2K.
  • ProShare Advisors first reported a position in OptiNose in Q4 2018 and held it in 12 quarters.
  • ProShare Advisors's OptiNose position peaked at $166K in Q1 2019.
  • 84 funds tracked by Wall St. Rank held OptiNose as of Q2 2024.

Based on ProShare Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.